Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients
Radim Dobiáš 1,2,†, Marcela Kánová 3,4,5,*,†, Nadežda Petejová 6,7,8, Štefan Kis Pisti 9, Robert Bocek 10, Eva Krejcí 1,2, Helena Stružková 2, Michaela Cachová 1, Hana Tomášková 11,12, Petr Hamal 13, Vladimír Havlícek 14,15,† and Milan Raška 16,†.1 Department of Bacteriology and Mycology, Public Health Institute in Ostrava, 702 00 Ostrava, Czech Republic; radim.dobias@zuova.cz (R.D.); eva.krejci@zuova.cz (E.K.); michaela.cachova@zuova.cz (M.C.)
2 Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic; helcastruzkova@seznam.cz
3 Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, 708 00 Ostrava, Czech Republic
4 Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, 710 00 Ostrava, Czech Republic
5 6 Department of Internal Medicine, University Hospital Ostrava, 708 00 Ostrava, Czech Republic; petejova@seznam.cz
7 Department of Internal Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic
8 Department of Internal Medicine III—Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic
9 Department of Anesthesiology and Resuscitation, Ostrava City Hospital, 728 80 Ostrava, Czech Republic
10 Department of Anesthesiology and Resuscitation, Hospital with Polyclinic Havířov, 736 01 Havířov, Czech Republic
11 Center of Health Services, Institute of Public Health in Ostrava, 702 00 Ostrava, Czech Republic
12 Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic
13 Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic
14 Institute of Microbiology of the Czech Academy of Sciences, 142 20 Prague, Czech Republic
15 Department of Analytical Chemistry, Faculty of Science, Palacký University, 771 46 Olomouc, Czech Republic
16 Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, 775 15 Olomouc, Czech Republic
* Correspondence: marcela.kanova@fno.cz
† These authors contributed equally to this work.
Presepsin as a predictor of septic shock in patients with urinary tract infection
Yoshitaka Sekine1*, Kazuhiko Kotani2, Daisuke Oka1, Hiroshi Nakayama1 et al.1 Department of Urology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi 371-8511, Japan
2 Division of Community and Family Medicine, Department of Clinical Laboratory Medicine, Jichi Medical University, Shimotsuke, Japan.
3 Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
*Correspondence: ysekine@gunma-u.ac.jp
Serum level of soluble CD14 subtype predicts long-term prognosis in sepsis patients with cardiac dysfunction
Junliang Liu1, Mingying Dai2, Hongyun Yang3, Lei Song1, Kun Chen4 et al.1 ICU, Renmin Hospital of Chengyang District, Qingdao, China; 2ICU, Affiliated Hospital of Qingdao University, Qingdao, China; 3ICU, General Hospital of Eastern Theater, Nanjing, China; 4ICU, Guannan Division, The First Renmin Hospital, Lianyungang, China
Contributions: (I) Conception and design: J Liu; (II) Administrative support: M Dai; (III) Provision of study materials or patients: H Yang, L Song; (IV) Collection and assembly of data: K Chen, Y Wang; (V)
Data analysis and interpretation: J Liu, M Hua; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
Correspondence to: Ming Hua. ICU, Guannan Division, The First Renmin Hospital, Lianyungang 222042, China. Email: hm2000lyg@163.com
Presepsin and Procalcitonin as Potential Biomarkers for Early Diagnosis and Prognosis of Sepsis in Critically Ill Patients
Reham Sabry 1, Hend Maghraby Maghraby 2*, Amany Mohamed Abd Allah 21 Clinical Pathology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
2 Internal Medicine Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
Email: *drhendms@gmail.com
Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication
Mohamed El-Saied El-Shafiea, Khaled M. Taemaa,❋, Moataz M. El-Hallaga, Abdallah Mohamed Abdallah KandeelbaCritical Care Medicine, Cairo University, Egypt
bCritical Care Medicine, El-Sahel Teaching Hospital, Egypt
Complementary Use of Presepsin with the Sepsis-3 Criteria Improved Identification of High-Risk Patients with Suspected Sepsis
Jong Eun Park1,2,†, Beomki Lee3,†, Sun Joo Yoon4, Chi-Min Park5,6, Chul Won Jung7, Myung-Ju Ahn7,Hyung-Doo Park3, Sung Yeon Hwang1, Tae Gun Shin1,* and Eun-Suk Kang3,*
1 Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of
Medicine, Seoul 06351, Korea; jongeun7.park@samsung.com (J.E.P.); sygood.hwang@samsung.com (S.Y.H.)
2 Department of Emergency Medicine, College of Medicine, Kangwon National University,
Chuncheon 24289, Korea
3 Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul 06351, Korea; beomki.lee@skku.edu (B.L.); nayadoo@hanmail.net (H.-D.P.)
4 Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Korea;
yoonsunjoo@gmail.com
5 Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of
Medicine, Seoul 06351, Korea; dr99.park@samsung.com
6 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine,
Seoul 06351, Korea
7 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul 06351, Korea; leukemia1@skku.edu (C.W.J.); silk.ahn@samsung.com (M.-J.A.)
* Correspondence: taegunshin@skku.edu (T.G.S.); eskang@skku.edu (E.-S.K.); Tel.: +82-2-3410-2053 (T.G.S.);
+82-2-3410-2703 (E.-S.K.)
† These authors contributed equally to this work.
Usefulness of presepsin in predicting the prognosis of patients with sepsis or septic shock: a retrospective cohort study
Jeong Suk Koh, Yoon Joo Kim, Da Hyun Kang, Jeong Eun Lee, Song-I LeeDepartment of Pulmonary and Critical Care Medicine, Chungnam National University School of Medicine, Daejeon, Korea
Presepsin and prognostic nutritional index are predictors of septic acute kidney injury, renal replacement therapy initiation in sepsis patients, and prognosis in septic acute kidney injury patients: a pilot study
Yuichiro Shimoyama1•, Osamu Umegaki1, Noriko Kadono1 and Toshiaki Minami2* Correspondence: shimocchiliebesfreud512@yahoo.co.jp
1 Department of Anesthesiology, Osaka Medical College, Intensive Care Unit, Osaka Medical College Hospital, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan
Presepsin level in predicting patients in-hospital mortality from sepsis under sepsis-3 criteria
Miao-Yun Wen1,*, Lin-Qiang Huang1,*, Fan Yang1,2, Jing-Kun Ye1,3, Geng-Xin Cai1,2, Xu-Sheng Li1,3, Hong-Guang Ding1, Hong-Ke Zeng11 Department of Emergency and Critical Care Medicine, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People’s Republic of China; 2 School of Medicine, South China University of Technology, Guangzhou, People’s Republic of China; 3The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People’s Republic of China
Presepsin values and Prognostic Nutritional Index predict mortality in intensive care unit patients with sepsis: a prospective observational study
Yuichiro Shimoyama ( icu003@osaka-med.ac.jp )Osaka Medical College
Osamu Umegaki
Osaka Medical College: Osaka Ika Daigaku
Noriko Kadono
Osaka Medical College: Osaka Ika Daigaku
Toshiaki Minami
Osaka Medical College: Osaka Ika Daigaku
Presepsin as a Potential Prognostic Marker for Sepsis According to Actual Practice Guidelines
Alice Nicoleta Dragoescu 1, Vlad Padureanu 2,* , Andreea Doriana Stanculescu 1,*, Luminit,a Cristina Chiut,u 1,Dan Nicolae Florescu 3, Ioana Andreea Gheonea 4, Rodica Padureanu 5 , Alex Stepan 6, Costin Teodor Streba 7,
Andrei Ioan Drocas,
8, Adriana Mihaela Ciocâlteu-Ionescu 3, Valeriu MarinS,
urlin 9 and Octavian
Craiova, Romania; alice.dragoescu@yahoo.com (A.N.D.); luminita.chiutu@gmail.com (L.C.C.)
2 Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
3 Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
nicku_dan@yahoo.co.uk (D.N.F.); adriana_ciocalteu@yahoo.com (A.M.C.-I.)
4 Department of Radiology and Medical Imaging, University of Medicine and Pharmacy of Craiova, 200349
Craiova, Romania; iagheonea@gmail.com
5 Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
zegheanurodica@yahoo.com
6 Department of Pathology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
astepan76@yahoo.com
7 Department of Research Methodology, University of Medicine and Pharmacy of Craiova, 200349 Craiova,
Romania; costinstreba@gmail.com
8 Department of Urology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania;
andrei_drocas@yahoo.com (A.I.D.); pdragoescu@yahoo.com (O.P.D.)
9 Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
vsurlin@gmail.com
* Correspondence: vldpadureanu@yahoo.com (V.P.); stanculescu.andreea@yahoo.com (A.D.S.)
Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients
Elham A. Hassan 1,*, Abeer S. Abdel Rehim 1, Asmaa O. Ahmed 2, Hanan Abdullahtif 2 andAlaa Attia 3
1 Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University,
Assiut 71111, Egypt; sharafabeer@yahoo.com
2 Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut 71111, Egypt;
asomar_12@yahoo.com (A.O.A.); Abdlatif@aun.edu.eg (H.A.)
3 Department of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut 71111, Egypt;
alaa.atya@med.au.edu.eg
* Correspondence: mam_elham75@yahoo.com; Tel.: +201002963415; Fax: +20882333327
Comparative study between complete blood picture indices and presepsin as early prognostic markers in septic shock patients
Faculty of Medicine, Alexandria University, Alexandria, Egypt
Individual and combined bioscore model of presepsin, procalcitonin, and high sensitive C - reactive protein as biomarkers for early diagnosis of paediatric sepsis
Samuel Asamoah Sakyi a,*, Anthony Enimil b, David Kwabena Adu a,c, Richard Dadzie Ephraim d,Kwabena Owusu Danquah e, Linda Fondjo a, David Baidoe-Ansah f, Prince Adoba a,
b Child Health Directorate, Komfo Anokye Teaching Hospital, School of Medical Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi,
Ghana
c College of Health and Well-Being, Kintampo, Ghana
d Department of Medical Laboratory Technology, Faculty of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana
e Department of Medical Laboratory Technology, Faculty of Allied Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
f Department of Physiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
g Laboratory Diagnostics, Ghana Health Service, Dansoman Polyclinic, Accra, Ghana
Association between elevation of plasma biomarkers and monocyte dysfunction and their combination in predicting sepsis: An observational single-centre cohort study
Jiabao Li1, Ziren Tang1, Miaorong Xie2, Chenchen Hang1,Medical University, PR China
2Department of Emergency Medicine, Beijing Friendship Hospital, Capital
Medical University, PR China
Presepsin values and Prognostic Nutritional Index predict mortality in intensive care unit patients with sepsis: a prospective observational study
Yuichiro Shimoyama ( icu003@osaka-med.ac.jp )Osaka Medical College
Osamu Umegaki
Osaka Medical College: Osaka Ika Daigaku
Noriko Kadono
Osaka Medical College: Osaka Ika Daigaku
Toshiaki Minami
Osaka Medical College: Osaka Ika Daigaku
Can presepsin uniformly respond to various pathogens? - an in vitro assay of new sepsis marker
Yusuke Koizumi1,2* , Daisuke Sakanashi2, Tetsuo Mohri2, Hiroki Watanabe1,2, Arufumi Shiota2, Nobuhiro Asai1,2,1Department of Clinical Infectious Diseases, Aichi Medical University Hospital,
1-1 Yazakokarimata, Nagakute, Aichi 480-1195, Japan
2Department of Infection Control, Aichi Medical University Hospital,
Nagakute, Aichi, Japan
Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
Presepsin values as markers of severity of sepsis
ª ICU Department, University Clinic of Infectious Diseases, Alexander Flemingu, 10000 Pristina, Kosovo
ᵇ ICU Department, University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”, Mirogojska 8,
10000 Zagreb, Croatia
Presepsin as a Biomarker for Sepsis Evolutions in Diabetis
Comparative study between complete blood picture indices and presepsin as early prognostic markers in septic shock patients
Comparative study between complete blood picture indices and presepsin as early prognostic
markers in septic shock patients, Egyptian Journal of Anaesthesia, 36:1, 118-125, DOI:
10.1080/11101849.2020.1789403
Presepsin values as markers of severity of sepsis
ᵇ ICU Department, University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”, Mirogojska 8,
10000 Zagreb, Croatia
ͨ “PROLAB” Biochemical Laboratory, Mark Dizdari, 10000 Pristina, Kosovo
٭Correspondence: ajete.aliu@gmail.com (Ajete Aliu-Bejta), barsicbruno@gmail.com (Bruno Baršić)
Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis
Department of Urology, Kyorin University School of Medicine, Shikawa
6-20-2, Mitaka, Tokyo 181-8611, Japan
Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice
Matjaz Jereb1, Matej Mavric1, Miha Skvarc2, Alja Drobnic1, Spela Dolenc1, Natalija Planinc Strunjas1, Boris Luksic3, Nina Grasselli Kmet11 Department of Infectious Diseases, University Medical Centre, Ljubljana, Slovenia
2 Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
3 Department of Infectious Diseases, Clinical Hospital Center, Split, Croatia
The value of serum presepsin in differentiating Gram-negative bacteria from Gram-positive bacteria and fungal infection in sepsis patients
2Department of Emergency and Critical Care Medicine, Guangdong Provincial People’s Hospital and
Guangdong Academy of Medical Sciences, Guangzhou 510080, China
Corresponding author:Wen Miaoyun, Email: wenmiaoyun041105@163.com
Clinical evaluation of presepsin considering renal function
Masashi MiyoshiID1*, Yusuke Inoue1, Mai Nishioka1, Akishige Ikegame1, Takayuki Nakao1,
Seiji Kishi2, Toshio Doi2, Kojiro Nagai2*
1 Department of Medical Technology, Tokushima University Hospital, Tokushima, Japan, 2 Department of
Nephrology, Tokushima University Hospital, Tokushima, Japan
Presepsin as a predictor of sepsis outcome in comparison with procalcitonin and C-reactive protein
University, Beni Suef, bCritical Care Medicine
Department, Cairo University, Giza, Egypt
Correspondence to Khaled M. Taema, MD,
7985 Almadeena Almonawara Street,
Mokattam, Cairo 11571, Egypt.
Tel: +20 100 041 2603;
e-mail: khaled.toaima@kasralainy.edu.eg
Presepsin level in predicting patients’ in-hospital mortality from sepsis under sepsis-3 criteria
Miao-Yun Wen1,*Lin-Qiang Huang1,*
Fan Yang1,2
Jing-Kun Ye1,3
Geng-Xin Cai1,2
Xu-Sheng Li1,3
Hong-Guang Ding1
Care Medicine, Guangdong Provincial
People’s Hospital and Guangdong
Academy of Medical Sciences,
Guangzhou, People’s Republic of China;
2School of Medicine, South China
University of Technology, Guangzhou,
People’s Republic of China; 3The Second
School of Clinical Medicine, Southern
Medical University, Guangzhou, People’s
this work
Сравнительная оценка активности эндотоксина и (точности) различных биомаркеров (ПСП, ПКТ, лактат, ИЛ-6) по отношению к инфекциям и исходам у пациентов, поступивших в отделение неотложной терапии
Toshiaki Ikeda 1,*, Hidenobu Kamohara 1, Shingo Suda 1, Takeo Nagura 1, Mikiko Tomino 2,Masatoshi Sugi 2 and Zen’ichiro Wajima 2
1 Division of Critical Care and Emergency Medicine, Tokyo Medical University Hachioji Medical Center,
Tokyo 193-0998, Japan
2 Department of Anesthesiology, Tokyo Medical University Hachioji Medical Center, Tokyo 193-0998, Japan
* Correspondence: toshi@tokyo-med.ac.jp; Tel.: +81-426-65-5611
Пресепсин - маркер тяжести септическоо процесса у больных с некротическим панкреатитом
Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia
Igor Stoma1,2, Igor Karpov1, Anatoly Uss2, Svetlana Krivenko2, Igor Iskrov2, Natalia Milanovich2,Svetlana Vlasenkova2, Irina Lendina2, Kristina Belyavskaya2, Veranika Charniak2
Correspondence: Igor Stoma (e-mail: igor.stoma@gmail.com).
Increased presepsin levels are associated with the severity of fungal bloodstream infections
Yuuki BambaID, Hiroshi MoroID*, Nobumasa Aoki, Takeshi Koizumi, Yasuyoshi Ohshima,Satoshi WatanabeID, Takuro Sakagami, Toshiyuki Koya, Toshinori Takada,
Toshiaki Kikuchi
Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical
and Dental Sciences, Niigata, Japan.
Значение пресепсина как раннего маркера гнойно-септических осложнений у пациентов с тяжелым панкреатитом
Н.Н. Салина*, В.П. Никулина, Р.Н. Борисов, М.А. ГодковЛаборатория клинической иммунологии, ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского Департамента здравоохранения
г. Москвы», Москва, Российская Федерация
Способ определения показаний к проведению селективной адсорбции эндотоксина у пациентов с сепсисом, вызванным грамотрицательными микроорганизмами
Автор(ы):Рогальская Екатерина Анатольевна (RU), Климович Людмила Григорьевна (RU), Плющ Марина Георгиевна (RU), Самсонова Наталья Николаевна (RU), Ярустовский Михаил Борисович (RU), Абрамян Марина Владимировна (RU).
Presepsin: Early Biomarker in Diagnosis of Sepsis in Emergency Department
Ovidiu Popa1, Diana Cimpoieșu1* and Carmen Dorobăț21Emergency Department, St. “Spiridon” Hospital Iași, “Gr. T. Popa” University of Medicine and Pharmacy, Iași, Romania
2Department of Infectious Disease, Clinic Infectious Diseases Hospital Iași, “Gr. T. Popa” University of Medicine and Pharmacy, Iași, Romania
Diagnostic Value of Presepsin in Sepsis
Silvana Teixeira Dal Ponte1*, Giordanna Andrioli 1, Luciano Passamani Diogo1, Renato Seligman2, Luciano Zubaran Goldani2, Andre Pinheiro Weber3, Gabriela Petitot Rezende4, Pauline Simas Machado41Emergency Physician, Emergency department, Hospital de Clinicas de Porto Alegre- Rs, Brazil
2Professor of Medicine, Universidade Federal do Rio Grande do Sul, Brazil
³Resident Emergency Medicine, Hospital de Pronto Socorro de Porto Alegre-RS, Brazil
4 Academic of Medicine, Universidade Federal do Rio Grande do Sul, Brazil
Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication
Mohamed El-Saied El-Shafie a , Khaled M. Taema a, ⇑ , Moataz M. El-Hallag a ,Abdallah Mohamed Abdallah Kandeel b
a, b
Critical Care Medicine, Cairo University, Egypt
Critical Care Medicine, El-Sahel Teaching Hospital, Egypt
Влияние искусственных дыхательных путей на исходы интенсивной терапии пожилых пациентов с острыми нарушениями мозгового кровообращения
КОХНО В.Н.1, КОМЗИН Д.В.2, РОГОВСКИХ В.Ю.2, ЛОКТИН Е.М.2, ШМАКОВ А.Н.1,ФЛЯГИН Т.С.2 1 Новосибирский Государственный Медицинский Университет
2 МБУЗ НСО Городская Клиническая Больница № 2
ВЕСТНИК НОВЫХ МЕДИЦИНСКИХ ТЕХНОЛОГИЙ
Том: 24, Номер: 1 Год: 2017 Страницы: 103-108
УДК: 616.831-005-036.11-053.9:616-039.72
Comparison of qSOFA (quick SOFA) Score, Presepsin, Procalcitonin and Lactate for Severity Assessment and Mortality Prediction in Patients with Initial Sepsis
E. Spanuth1, H. Ebelt2, B. Ivandic3, R. Thomae4, K. Werdan2. 1DIAneering - Diagnostics Engineering & Research,Heidelberg, Germany, 2Department of Medicine III, University Clinics Halle (Saale), Martin-Luther- University Halle-Wittenberg,
Halle, Germany, 3Department of Medicine III, University of Heidelberg; DIAneering
– Diagnostics Engineering & Research, Heidelberg, Germany, 4Mitsubishi Chemical Europe, Düsseldorf, Germany
Comparison of lactate, presepsin and procalcitonin with the new Qsofa (quick sofa) score for severity assessment and mortality Prediction in patients with initial sepsis
E. Spanuth 3, H. Ebelt 1, B. Ivandic 2, R. Thomae 4, K. Werdan 11Department of Medicine III, University Clinics Halle (Saale), Martin-Luther-University Halle- Wittenberg, Germany
2Department of Medicine III, University of Heidelberg, Heidelberg, Germany; DIAneering – Diagnostics Engineering & Research
GmbH, Heidelberg, Germany
3DIAneering – Diagnostics Engineering & Research GmbH, Heidelberg, Germany
4Mitsubishi Chemical Europe, Düsseldorf, Germany
Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication
Mohamed El-Saied El-Shafie a, Khaled M. Taema a,⇑, Moataz M. El-Hallag a,Abdallah Mohamed Abdallah Kandeel b
a Critical Care Medicine, Cairo University, Egypt
b Critical Care Medicine, El-Sahel Teaching Hospital, Egypt
Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies
Satoru Nanno1, Hideo Koh1, Takako Katayama 1, Masamichi Hashiba 2, Ayumi Sato 2,Yosuke Makuuchi1, Joji Nagasaki 1, Masatomo Kuno1, Takuro Yoshimura 1, Hiroshi Okamura1,
Mitsutaka Nishimoto 1, Asao Hirose 1, Mika Nakamae1, Takahiko Nakane 1,
Masayuki Hino1 and Hirohisa Nakamae1
Прeсепсин пригоден для ранней диагностики сепсиса согласно новому международному определению СЕПСИС-3
EuSEM congress,Vienna, 2-5 October, 2016.AbstractsTomonori YAMAMOTO, Yamamoto HIROMASA, Tetsuro Nishimura TETSURO,
Shinyama NAOKI, Noda TOMOHIRO, Shinichiro KAGA, Takahumi TERADA,
Kenichiro UCHIDA, Takasei MORIOKA, Hiroharu TAKESADA, Maiko ESAKI, Hoshi
HIMURA, Yasumitsu MIZOBATA
Clinical Impact of Kidney Function on Presepsin Levels
Takanobu Nagata1, Yoshinari Yasuda1, Masahiko Ando2, Tomoko Abe1,Takayuki Katsuno1, Sawako Kato1, Naotake Tsuboi1, Seiichi Matsuo1,
Shoichi Maruyama1*
1 Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2 Center for
Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan
Combined assessment of presepsin (scd14-st) and mortality in Emergency department sepsis (meds) score improves outcome prediction of sepsis
E. Spanuth1, B. Ivandic1, J. Wilhelm3, R. Thomae2, K. Werdan31DIAneering - Diagnostics Engineering & Research, Heidelberg, Germany
2Mitsubishi Chemical Europe, Düsseldorf, Germany
3University Clinics Halle (Saale), Department of Medicine III, Martin-Luther-University
Halle-Wittenberg, Germany
Diagnostic and prognostic performance of PATHFAST Presepsin in patients with SIRS and early sepsis
E Spanuth1, R Carpio2, R Thomae31DIAneering GmbH, Heidelberg, Germany; 2Hospital Nacional Edgardo
Rebagliati Martins-EsSalud, Lima, Peru; 3Mitsubishi Chemical Europe,
Dьsseldorf, Germany
Critical Care 2015, 19(Suppl 1):P63 (doi: 10.1186/cc14143)
Determination of reference interval for presepsin, an early marker for sepsis
Davide Giavarina, Mariarosa Carta. Determination of reference interval for presepsin, an early marker for sepsis. Biochemia Medica 2015;25(1):64-8. http://dx.doi.org/10.11613/BM.2015.007 Clinical Chemistry and Haematology Laboratory, San Bortolo Hospital, Vicenza, ItalyAssessment of the usefulness of Presepsin (soluble CD14 subtype; sCD14-ST) in septic patients
Takeshi Nishida1, Hiroyasu Ishikura1, Akira Murai1, Yuhei Irie1, Takehiro Umemura1, Takanori Kamitani1, Shigeatsu Endo2, The Presepsin Workshop1 Department of Emergency and Critical Care Medicine, Fukuoka University Hospital, Fukuoka, JAPAN
2 Department of Critical Care Medicine, School of Medicine, Iwate Medical University, Iwate, JAPAN
Presepsin (soluble CD14 subtype) Is Secreted from Human Monocytes after Phagocytosis
Yasuyuki Arai, MD1, Kouhei Yamashita, MD, PhD1, Kiyomi Mizugishi,MD, PhD1 and Akifumi Takaori-Kondo, M.D., Ph.D.2
Department of Hematology and Oncology, Kyoto University Graduate
School of Medicine, Kyoto, Japan
Department of Hematology and Oncology, Graduate School of Medicine,
Kyoto University, Kyoto, Japan
Роль продленной вено-венозной гемофильтрации в коррекции липополисахаридемии и ассоциированных с ней маркеров грамотрицательного сепсиса
Р.М. Зайцев, А.Ю. Яковлев, А.В. Абрамов, С.Ю. Власкин,М.Ю. Серопян, А.А. Ниязматов, А.Ю. Сморкалов, Е.Ю. Голубцова
ГБУЗ НО «Нижегородская областная клиническая больница им. Н.А. Семашко»
Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study
Marco Ulla, Elisa Pizzolato, Manuela Lucchiari, Maria Loiacono, Flavia Soardo, Daniela Forno,Fulvio Morello, Enrico Lupia, Corrado Moiraghi, Giulio Mengozzi and Stefania Battista
Ulla et al. Critical Care 2013, 17:R168